1. Home
  2. ARQT vs NG Comparison

ARQT vs NG Comparison

Compare ARQT & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • NG
  • Stock Information
  • Founded
  • ARQT 2016
  • NG 1984
  • Country
  • ARQT United States
  • NG Canada
  • Employees
  • ARQT N/A
  • NG N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • NG Precious Metals
  • Sector
  • ARQT Health Care
  • NG Basic Materials
  • Exchange
  • ARQT Nasdaq
  • NG Nasdaq
  • Market Cap
  • ARQT 1.7B
  • NG 1.5B
  • IPO Year
  • ARQT 2020
  • NG N/A
  • Fundamental
  • Price
  • ARQT $15.25
  • NG $4.91
  • Analyst Decision
  • ARQT Strong Buy
  • NG Buy
  • Analyst Count
  • ARQT 6
  • NG 1
  • Target Price
  • ARQT $18.80
  • NG $7.00
  • AVG Volume (30 Days)
  • ARQT 1.9M
  • NG 4.0M
  • Earning Date
  • ARQT 08-13-2025
  • NG 06-25-2025
  • Dividend Yield
  • ARQT N/A
  • NG N/A
  • EPS Growth
  • ARQT N/A
  • NG N/A
  • EPS
  • ARQT N/A
  • NG N/A
  • Revenue
  • ARQT $212,819,000.00
  • NG N/A
  • Revenue This Year
  • ARQT $61.01
  • NG N/A
  • Revenue Next Year
  • ARQT $37.95
  • NG N/A
  • P/E Ratio
  • ARQT N/A
  • NG N/A
  • Revenue Growth
  • ARQT 100.03
  • NG N/A
  • 52 Week Low
  • ARQT $7.86
  • NG $2.26
  • 52 Week High
  • ARQT $17.75
  • NG $5.06
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 65.06
  • NG 68.28
  • Support Level
  • ARQT $13.06
  • NG $4.34
  • Resistance Level
  • ARQT $15.36
  • NG $5.01
  • Average True Range (ATR)
  • ARQT 0.65
  • NG 0.24
  • MACD
  • ARQT 0.22
  • NG 0.06
  • Stochastic Oscillator
  • ARQT 91.54
  • NG 93.20

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About NG Novagold Resources Inc.

Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other presious metals.

Share on Social Networks: